Seeking Alpha

Building on past work, Qiagen (QGEN) enters into a collaboration agreement with Eli Lilly (LLY)...

Building on past work, Qiagen (QGEN) enters into a collaboration agreement with Eli Lilly (LLY) for the development and commercialization of companion diagnostics for pairing with LLY's investigational and approved medicines across all therapeutic areas. Companion diagnostics unlock a patient's molecular information in order to guide treatment decisions for specific cancers or other diseases. Financial terms of the agreement aren't disclosed.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|